[HTML][HTML] Pollen-derived microcapsules for aspirin microencapsulation: in vitro release and physico-chemical studies
Aspirin, also known as acetylsalicylic acid (ASA), is one of the most crucial therapies needed
and/or used in a basic health system. Using biocompatible materials to encapsulate ASA …
and/or used in a basic health system. Using biocompatible materials to encapsulate ASA …
Non-aqueous olive oil-in-glycerin (o/o) Pickering emulsions: Preparation, characterization and in vitro aspirin release
Non-aqueous olive oil-in-glycerin Pickering emulsions are successfully prepared and
stabilized solely by hydrophobic silica nanoparticles possessing 50% silanol groups …
stabilized solely by hydrophobic silica nanoparticles possessing 50% silanol groups …
Association between low-dose aspirin and uric acid in the elderly: an observational retrospective cross-sectional study
JR Li, Y Fan, ML Liu - International journal of general medicine, 2021 - Taylor & Francis
Purpose Uric acid is an independent factor for arteriosclerotic cardiovascular disease
(ASCVD). Although aspirin is one of the most widely used agent in patients with ASCVD …
(ASCVD). Although aspirin is one of the most widely used agent in patients with ASCVD …
缺血性脑血管病介入治疗抗血小板策略中国专家共识
马宁 - 中华医学杂志, 2015 - cqvip.com
缺血性脑血管病致残, 病死及卒中复发率高, 给家庭及社会造成极大的经济负担[1-3].
越来越多的临床研究显示, 血管内介入治疗能显著地降低缺血性脑血管病的致残 …
越来越多的临床研究显示, 血管内介入治疗能显著地降低缺血性脑血管病的致残 …
Preparation and drug release of aspirin-loaded PLGA-PEG-PLGA/montmorillonite microparticles
HJ Liu, HC Chu, LH Lin, SY Hsu - International Journal of …, 2015 - Taylor & Francis
A polymerization method was used to synthesize biodegradable poly (lactide-co-
glycolide)/poly (ethyleneglycol)/poly (lactide-co-glycolide)(PLGA-PEG-PLGA) copolymers …
glycolide)/poly (ethyleneglycol)/poly (lactide-co-glycolide)(PLGA-PEG-PLGA) copolymers …
[HTML][HTML] Effects of low-dose aspirin on the osseointegration process in rats
AC Lupepsa, P Vargas-Sanchez, MG Moro… - International Journal of …, 2021 - Springer
Background Several drugs are capable of promoting changes in bone metabolism. The aim
of this study was to evaluate the effect of long-term low-dose aspirin (LDA) therapy on …
of this study was to evaluate the effect of long-term low-dose aspirin (LDA) therapy on …
[HTML][HTML] Association of Hematuria with Renal Progression and Survival in Patients Who Underwent Living Donor Liver Transplant
KC Chang, YP Hsieh, HN Chao, CM Lin… - Journal of Clinical …, 2021 - mdpi.com
Background: This study aimed to determine the association between episodic or persistent
hematuria after liver transplantation and long-term renal outcomes. Methods: Patients who …
hematuria after liver transplantation and long-term renal outcomes. Methods: Patients who …
阿司匹林联合阿托伐他汀和单独阿司匹林对缺血性卒中患者高尿酸血症发生率及卒中复发率影响的对比研究
温淼， 杨波， 于丹丹， 张婧， 杨中华， 刘丽萍 - 中国全科医学, 2016 - cqvip.com
目的比较阿司匹林联合阿托伐他汀和单独阿司匹林对缺血性卒中患者高尿酸血症发生率和卒中
复发率的影响. 方法选取2012 年3 月—2013 年3 月首都医科大学附属北京天坛医院神经内科 …
复发率的影响. 方法选取2012 年3 月—2013 年3 月首都医科大学附属北京天坛医院神经内科 …
[PDF][PDF] 慢性肾脏病透析患者的抗血小板治疗策略
王佳， 余毅 - 世界临床药物, 2016 - jwph.com.cn
心脑血管系统疾病是慢性肾脏病(CKD) 5 期透析患者的主要死因之一, 然而目前对于CKD 5
期透析患者的抗血小板治疗尚无可供参考的相关指南. 本文结合近年抗血小板药物相关研究 …
期透析患者的抗血小板治疗尚无可供参考的相关指南. 本文结合近年抗血小板药物相关研究 …
Risk factors for secondary hyperuricemia in arterial hypertension. Review.
ST Abisheva, TE Batyrkhan, TV Vinnik - 2023 - cabidigitallibrary.org
Background. According to large epidemiological studies, a link has been established
between hyperuricemia (HU) and a high risk of cardiovascular diseases, including serious …
between hyperuricemia (HU) and a high risk of cardiovascular diseases, including serious …